Recovering optic neuritis during systemic cisplatin and carboplatin chemotherapy

Acta Neurologica Scandinavica

Volumn 96, Issue 4, 1997, Pages 260-261

  Caraceni, A ^a   Martini, C ^a   Spatti, G ^a   Thomas, A ^b   Onofrj, M ^b,c  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b UNIVERSITY OF CHIETI   (Italy)

^c Ospedale SS Annunziata   (Italy)

Author keywords

Carboplatin; Cisplatin; Neurotoxicity; Optic neuropathy; Ovarian cancer

Indexed keywords

CARBOPLATIN; CISPLATIN;

ADULT; ARTICLE; CANCER CHEMOTHERAPY; CASE REPORT; ELECTRORETINOGRAPHY; FEMALE; HUMAN; OPTIC NERVE DISEASE; OVARY CARCINOMA;

EID: 0030825117     PISSN: 00016314     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0404.1997.tb00280.x     Document Type: Article

References (9)

1. POSNER JB. Side effects of chemotherapy. In POSNER JB. Neurologic complications of cancer. Philadelphia: F.A. Davis, 1995: 264-310.
2. GREGG RW, MOLEPO MJ, MONPETIT VJA et al. Cisplatin neurotoxicity: the relationship between dosage, time and platinum concentration in neurologic tissues, and morphologic evidence of toxicity. J Clin Oncol 1992: 10: 795-803.
3. OSTROW S, HAHN D, WIERNIK PH, RICHARDS RD. Ophthalmic toxicity after cis-dichlorodiaminoplatinum (II) therapy. Cancer Treat Rep 1978: 62: 1591-4.
4. BECHER R, SCHUTT P, OSIEKA R, SCHMIDT CG. Peripheral neuropathy and ophthalmologic toxicity after treatment with cisdichlorodiaminoplatinum II. J Cancer Res Clin Oncol 1980: 96: 219-21.
5. WALSH TJ, CLARK W, PARHAD IM, GREEN WR. Neurotoxic effects of cisplatin therapy. Arch Neurol 1982: 39: 719-20.
6. GRAUS F, ELKON KB, CORDON-CARDO C, POSNER JB. Sensory neuronopathy and small cell lung cancer. Antineuronal antibody that also reacts with the tumor. Am J Med 1986: 80: 45-52.
7. THIRKILL CE, FITZGERALD P, SERGOTT RC, ROTH AM, TYLER NK, KELTNER JL. Cancer associated retinopathy (CAR-syndrome) with antibodies reacting with retinal, optic nerve cancer cells. N Engl J Med 1989: 321: 1589-94.
8. CELESIA GG, BODIS-WOLLNER I, CHATRIAN EG, HARDING GFA, SOKOL S, SPEKREIJES H. Recommended standards for electroretinograms and visual evoked potentials. Report of an IFCN Committee. Electroenceph Clin Neurophysiol 1993: 87: 421-36.
9. MAIESE K, WALKER RW, GARGAN R, VICTOR JD. Intraarterial cisplatin associated optic and otic toxicity. Arch Neurol 1992: 49: 83-6.